Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

PCOS often causes skin issues like excess hair, acne, hair thinning, and dark patches due to hormone imbalances and insulin resistance.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Too much androgen can cause hair loss; finasteride may help.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Testosterone may slow down wound healing and increase inflammation.

Herbal extracts and platelet-rich plasma together may help increase hair growth by making certain cells grow more, through specific cell growth pathways.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.